Taken together, these data underline the effects of SAPAP3 on the three different neurotransmitters, indicating its role in the glutamate–monoamine interplay and representing a neurobiological underpinning for OCS in schizophrenia [212,311]. The gene discussed is DLGAP3; the disease is schizophrenia.